Delivery Order SPE2DB22D2007-SPE2DB25FJ4XT
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $6.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of 5,000 unit vials of Thrombin-JMI, a specialty pharmaceutical product, with a potential value of $1,615.50. The contract has a completion date of March 6, 2024 and was awarded on March 5, 2024. No set-aside designation was...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $16,136.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a topical thrombin product used in surgical hemostasis. Issued on August 22, 2025, with an ultimate completion date of August 25, 2025, this non-set-aside contract represents a child delivery order under AmerisourceBergen's larger prime indefinite delivery contract (IDC SPE2DX) valued at $999,999,999.00 through December...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications, with a firm fixed price ceiling value of $6,998.20. The award, executed on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitively awarded, non-set-aside contract. The contract will be fulfilled from AmerisourceBergen's operations in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 5, 2025, for the supply of Activase 50 mg vials valued at $3,207.38. This non-set-aside, competitively awarded contract features firm fixed pricing and an ultimate completion date of August 6, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain, a component of the Department of Defense, and is being performed at the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 31, 2025, for 20,000 unit vials of Recothrom with a ceiling value of $30,646.93. The contract represents a non-competitive, non-set-aside award with an ultimate completion date of August 1, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,264.90 to AmerisourceBergen Drug Corp on August 5, 2025, with a completion deadline of August 6, 2025. This firm fixed-price delivery order, classified as a child contract under the company's larger indefinite delivery vehicle with DLA Troop Support Medical, represents a competitively awarded, non-set-aside transaction. The award was made to AmerisourceBergen's Corporate Office division, headquartered...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $13,612.00 to AmerisourceBergen Drug Corp on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, contract number 4568962311, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $1,219.17 to AmerisourceBergen Drug Corp on September 11, 2025, with an ultimate completion date of September 12, 2025. The order is for pharmaceutical products identified as "4569424878 ! DT 1C 2.25X4 700/RL 6RL/BX DHAPCL" under a firm fixed price contract type with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $10,873.56 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $10,976.50 to AmerisourceBergen Drug Corp on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX). The order is to be fulfilled at AmerisourceBergen's corporate office...